Baker Bros. Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $709K | Sell |
|
|||||
|
2022
Q1 | $4.45M | Hold |
|
|||||
|
2021
Q4 | $5.17M | Hold |
|
|||||
|
2021
Q3 | $6.13M | Hold |
|
|||||
|
2021
Q2 | $5.75M | Hold |
|
|||||
|
2021
Q1 | $8.48M | Buy |
|
|||||
|
2020
Q4 | $3.23M | Sell |
|
|||||
|
2020
Q3 | $1.88M | Sell |
|
|||||
|
2020
Q2 | $2.46M | Sell |
|
|||||
|
2020
Q1 | $3.08M | Hold |
|
|||||
|
2019
Q4 | $4.62M | Hold |
|
|||||
|
2019
Q3 | $3.46M | Hold |
|
|||||
|
2019
Q2 | $3.66M | Buy |
|